Latest Breaking News On - Venereology congress - Page 7 : comparemela.com

MoonLake Immunotherapeutics presents positive 12-week data from the Phase 2 MIRA trial with Nanobody® Sonelokimab for Hidradenitis Suppurativa at the European Academy of Dermatology and Venereology Congress

MoonLake Immunotherapeutics presents positive 12-week data
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Ireland
Switzerland
Dublin
Berlin
Germany
Moonlake-immunotherapeutics
Mary-jane-elliott
Namrata-taak
Matthias-bodenstedt
Ashley-tapp
Patricia-sousa
Hidradenitis-suppurativa

MoonLake Immunotherapeutics AG: MoonLake Immunotherapeutics presents positive 12-week data from the Phase 2 MIRA trial with Nanobody® Sonelokimab for Hidradenitis Suppurativa at the European Academy of Dermatology and Venereology Congress
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Ireland
Switzerland
Berlin
Germany
Dublin
Hidradenitis-suppurativa
Ashley-tapp
Kristian-reich
Mary-jane-elliott
Moonlake-immunotherapeutics
Matthias-bodenstedt
Patricia-sousa